Related Experiment Video
Updated: May 5, 2026

09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
8.7K
AMD-Mamba: A Phenotype-Aware Multi-Modal Framework for Robust AMD Prognosis
Puzhen Wu1, Mingquan Lin2, Qingyu Chen3
1Department of Population Health Sciences, Weill Cornell Medicine, New York, NY 10022, USA.
Arxiv
|September 19, 2025
Summary
We developed AMD-Mamba, a new AI framework and biomarker for predicting age-related macular degeneration (AMD) progression. This tool integrates imaging, genetic, and demographic data for earlier detection of high-risk patients.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Genetics
Background:
- Age-related macular degeneration (AMD) is a primary cause of irreversible vision loss.
- Accurate prognosis of AMD is essential for prompt clinical intervention.
- Existing prognostic models often lack comprehensive data integration and advanced feature extraction.
Purpose of the Study:
- To introduce AMD-Mamba, a novel multi-modal framework for AMD prognosis.
- To develop and validate a new AMD biomarker for improved disease progression prediction.
- To enhance the early detection of high-risk AMD patients.
Main Methods:
- Developed AMD-Mamba, a multi-modal framework integrating color fundus images, genetic variants, and socio-demographic data.
- Employed a novel metric learning strategy using AMD severity scale scores for richer feature representation.
- Utilized Vision Mamba for fused local and global information extraction, alongside multi-scale fusion of image and clinical data.
Main Results:
- The proposed AMD biomarker demonstrated significant predictive power for AMD progression.
- AMD-Mamba achieved improved detection of high-risk AMD patients in early stages when combined with existing variables.
- Experimental validation on the AREDS dataset (45,818 images, 52 genetic variants, 3 socio-demographic variables from 2,741 subjects) confirmed the framework's efficacy.
Conclusions:
- AMD-Mamba offers a promising multi-modal approach for precise AMD prognosis.
- The novel biomarker significantly contributes to identifying individuals at high risk for AMD progression.
- This framework facilitates proactive and personalized management strategies for age-related macular degeneration.
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21

